Colon Cancer clinical trials

Explore recruiting colon cancer clinical trials.

Recruiting colon cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colon Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, open label, randomized study of neoadjuvant dostarlimab plus CAPEOX versus CAPEOX in participants with previously untreated T4N0 or Stage III MMRp/ MSS colon cancer

Belgium, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high risk colon cancer patients. - The PIPAC-OPC3 CC trial,

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II randomized trial to assess the effect of intensive vs standard adjuvant chemotherapy in localised colon cancer with circulating tumor DNA

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II study of neoadjuvant Dostarlimab in patients with untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Neoadjuvant immune checkpoint inhibition and novel IO combinations in early-stage colon cancer - the NICHE trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

POST-SURGICAL LIQUID BIOPSY - GUIDED TREATMENT OF STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE PEGASUS TRIAL

Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Colon Cancer trials by city

Colon Cancer in Toronto Colon Cancer in Vancouver Colon Cancer in Montreal Colon Cancer in Calgary Colon Cancer in Edmonton Colon Cancer in Ottawa Colon Cancer in Winnipeg Colon Cancer in Quebec City Colon Cancer in Hamilton Colon Cancer in Kitchener Colon Cancer in London Colon Cancer in Halifax Colon Cancer in New York Colon Cancer in Los Angeles Colon Cancer in Chicago Colon Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease